MOLECULAR GENETIC ANALYSIS OF THE RENIN–ANGIOTENSIN SYSTEM IN CHRONIC KIDNEY DISEASE
Keywords:
chronic kidney disease, renin–angiotensin system, molecular genetic factorsAbstract
This study examined polymorphisms of the AGTR1 and AGTR2 genes in 153 patients with chronic kidney disease (CKD). Molecular genetic analysis revealed an increased frequency of single nucleotide polymorphisms in these genes, which influence the activity of the renin–angiotensin system. It was found that CKD progression is associated with the presence of the C allele of the AGTR1 gene (encoding the angiotensin II type 1 receptor) and the G allele of the AGTR2 gene (encoding the angiotensin II type 2 receptor).
References
Arima, Y.; Fukuoka, H. Developmental origins of health and disease theory in cardiology. J. Cardiol. 2020, 76, 14–17.
Bagby, S.P. Maternal nutrition, low nephron number, and hypertension in later life: Pathways of nutritional programming. J. Nutr. 2007, 137, 1066–1072.
Chevalier, R.L. Evolution, kidney development, and chronic kidney disease. Semin. Cell Dev. Biol. 2019, 91, 119–131.
Fleming, T.P.; Velazquez, M.A.; Eckert, J.J. Embryos, DOHaD and David Barker. J. Dev. Orig. Health Dis. 2015, 6, 377–383.
Hanson, M.; Gluckman, P. Developmental origins of noncommunicable disease: Population and public health implications. Am. J. Clin. Nutr. 2011, 94, 1754S–1758S.
Hanson, M.A.; Gluckman, P.D. Early developmental conditioning of later health and disease: Physiology or pathophysiology? Physiol. Rev. 2014, 94, 1027–1076.
Hoffman, D.J.; Powell, T.L.; Barrett, E.S.; Hardy, D.B. Developmental origins of metabolic diseases. Physiol. Rev. 2021, 101, 739–795.
Iturzaeta, A.; Sáenz Tejeira, M.M. Early programming of hypertension. Arch. Argent. Pediatr. 2022, 120, e8–e16.
Jaradat, J.H.; Nashwan, A.J. Cardiovascular-kidney-metabolic syndrome: Understanding the interconnections and the need for holistic intervention. J. Med. Surg. Public Health 2023, 1, 100028.
Kett, M.M.; Denton, K.M. Renal programming: Cause for concern? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300, R791–R803.
Ndumele, C.E.; Rangaswami, J.; Chow, S.L.; Neeland, I.J.; Tuttle, K.R.; Khan, S.S.; Coresh, J.; Mathew, R.O.; Baker-Smith, C.M.; Carnethon, M.R.; et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation 2023, 148, 1606–1635.
Paauw, N.D.; van Rijn, B.B.; Lely, A.T.; Joles, J.A. Pregnancy as a critical window for blood pressure regulation in mother and child: Programming and reprogramming. Acta Physiol. 2017, 219, 241–259.
Saavedra, L.P.J.; Piovan, S.; Moreira, V.M.; Gonçalves, G.D.; Ferreira, A.R.O.; Ribeiro, M.V.G.; Peres, M.N.C.; Almeida, D.L.; Raposo, S.R.; da Silva, M.C.; et al. Epigenetic programming for obesity and noncommunicable disease: From womb to tomb. Rev. Endocr. Metab. Disord. 2023; Online ahead of print.
Schwacke, J.H.; Spainhour, J.C.; Ierardi, J.L.; Chaves, J.M.; Arthur, J.M.; Janech, M.G.; Velez, J.C. Network modeling reveals steps in Angiotensin peptide processing. Hypertension 2013, 61, 690–700.
Tain, Y.-L., & Hsu, C.-N. (2024). The Renin–Angiotensin System and Cardiovascular–Kidney–Metabolic Syndrome: Focus on Early-Life Programming. International Journal of Molecular Sciences, 25(6), 3298.
Tain, Y.L.; Joles, J.A. Reprogramming: A Preventive Strategy in Hypertension Focusing on the Kidney. Int. J. Mol. Sci. 2016, 17, 23.
Yvan-Charvet, L.; Quignard-Boulangé, A. Role of adipose tissue renin-Angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int. 2011, 79, 162–168.
